Living donor transplant education for African American patients with end-stage renal disease

被引:44
|
作者
Arriola, Kimberly R. Jacob [1 ]
Powell, C. Lamonte [1 ]
Thompson, Nancy J. [1 ]
Perryman, Jennie P. [2 ]
Basu, Mohua [1 ]
机构
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Transplant Ctr, Atlanta, GA USA
关键词
RANDOMIZED CONTROLLED-TRIAL; KIDNEY-TRANSPLANTATION; ORGAN DONATION; RACIAL DISPARITIES; INTERVENTION; BARRIERS; TALK; WILLINGNESS; PREFERENCES; CANDIDATES;
D O I
10.7182/pit2014830
中图分类号
R61 [外科手术学];
学科分类号
摘要
Context-Despite numerous benefits of live donor kidney transplant (LDKT), patient-level barriers often prevent African Americans from considering LDKT. Educational interventions designed to address patient-level barriers may increase willingness among African American patients with end-stage renal disease to explore LDKT as a treatment option. Objective-To assess the effectiveness of a culturally sensitive educational inter-vention called Living ACTS (About Choices in Transplantation and Sharing) that was designed to address patient-level barriers to LDKT among African American patients with end-stage renal disease. Design/Participants-Patients were randomized to intervention (n = 136) or control (n =132) groups. They completed baseline measures and then viewed either the Living ACTS or control video. Both groups then completed an immediate followup measure and a 6-month assessment administered via telephone. Main Outcome Measures-Self-reported knowledge about LDKT, willingness to talk to the patient's family about LDKT, and perceived benefits of LDKT were measured at 3 time points. Results-At 6-month follow-up, intervention participants demonstrated a significantly greater increase in knowledge of LDKT than control participants (F-2,F-229=3.08, P=.05). Intervention participants expressed greater willingness to talk to patients' families about LDKT than did control participants from baseline through 6-month follow-up (F-1,F-230 = 7.11, P=.008). Finally, at immediate follow-up, intervention participants reported greater endorsement of the benefits of LDKT than did control participants (F-2,F-23=14.27, P < .001); however, this effect had disappeared by the 6-month follow-up. Conclusions Living ACTS is effective at increasing and maintaining knowledge about LDKT among African American patients with end-stage renal disease who are considering transplant. (C) 2014 NATCO, The Organization for Transplant Professionals
引用
收藏
页码:362 / 370
页数:9
相关论文
共 50 条
  • [21] Perceptions about hemodialysis and transplantation among African American adults with end-stage renal disease: inferences from focus groups
    Salter, Megan L.
    Kumar, Komal
    Law, Andrew H.
    Gupta, Natasha
    Marks, Kathryn
    Balhara, Kamna
    McAdams-DeMarco, Mara A.
    Taylor, Laura A.
    Segev, Dorry L.
    BMC NEPHROLOGY, 2015, 16
  • [22] Geographic Variation in End-Stage Renal Disease Incidence and Access to Deceased Donor Kidney Transplantation
    Mathur, A. K.
    Ashby, V. B.
    Sands, R. L.
    Wolfe, R. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (04) : 1069 - 1080
  • [23] Renal Transplant in Elderly End-Stage Renal Disease Patients: Impact of Comorbidities and Posttransplant Adverse Events on Outcomes
    Hamdy, Mohamed Yehia
    EL-Aggan, Hayam
    EL Gohary, Iman
    Halawa, Ahmed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (02) : 93 - 102
  • [24] IMPORTANCE OF PLATELET AGGREGATION IN PATIENTS WITH END-STAGE RENAL DISEASE
    Martinovic, Zeljka
    Basic-Jukic, Nikolina
    Pavlovic, Daniela Bandic
    Kes, Petar
    ACTA CLINICA CROATICA, 2013, 52 (04) : 472 - 477
  • [25] Improving Outcomes in Patients with Lupus and End-Stage Renal Disease
    Inda-Filho, Antonio
    Neugarten, Joel
    Putterman, Chaim
    Broder, Anna
    SEMINARS IN DIALYSIS, 2013, 26 (05) : 590 - 596
  • [26] Psychological problems of end-stage renal disease (ESRD) patients
    Kikuchi, M
    Fukunishi, I
    CUTTING EDGE MEDICINE AND LIAISON PSYCHIATRY: PSYCHIATRIC PROBLEMS OF ORGAN TRANSPLANTATION, CANCER, HIV/AIDS AND GENETIC THERAPY, 1999, 1174 : 159 - 167
  • [27] Management of hepatitis C in patients with end-stage renal disease
    Berenguer M.
    Aguilera V.
    Current Hepatitis Reports, 2010, 9 (1) : 38 - 46
  • [28] Acute myocardial infarction in patients with end-stage renal disease
    Herzog, CA
    KIDNEY INTERNATIONAL, 1999, 56 : S130 - S133
  • [29] Pretransplant Thyroid Findings in Patients With End-Stage Renal Disease
    Akcay, Eda Yilmaz
    Tepeoglu, Merih
    Ozdemir, Binnaz Handan
    Ozgun, Gonca
    Kazanci, Semih
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 : 67 - 70
  • [30] A road map for patients with imminent end-stage renal disease
    Burkhalter, Felix
    Steiger, Juerg
    Dickenmann, Michael
    SWISS MEDICAL WEEKLY, 2012, 142